Kainos Medicine Stock Probability Of Bankruptcy
| 284620 Stock | 2,895 155.00 5.08% |
Kainos |
Kainos Medicine Company chance of distress Analysis
Kainos Medicine's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Kainos Medicine Probability Of Bankruptcy | Less than 25% |
Most of Kainos Medicine's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kainos Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Kainos Medicine probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Kainos Medicine odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Kainos Medicine financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Kainos Medicine has a Probability Of Bankruptcy of 25.0%. This is much higher than that of the sector and significantly higher than that of the Probability Of Bankruptcy industry. The probability of bankruptcy for all Republic of Korea stocks is notably lower than that of the firm.
Kainos Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kainos Medicine's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kainos Medicine could also be used in its relative valuation, which is a method of valuing Kainos Medicine by comparing valuation metrics of similar companies.Kainos Medicine is currently under evaluation in probability of bankruptcy category among related companies.
Kainos Fundamentals
| Return On Equity | -57.31 | |||
| Current Valuation | 17.74 B | |||
| Shares Outstanding | 5.4 M | |||
| Shares Owned By Insiders | 25.33 % | |||
| Shares Owned By Institutions | 0.14 % | |||
| Revenue | 1.66 B | |||
| Net Income | (16.23 B) | |||
| Cash And Equivalents | 23.23 B | |||
| Total Debt | 1.63 B | |||
| Cash Flow From Operations | (9.2 B) | |||
| Market Capitalization | 31.27 B | |||
| Total Asset | 41.96 B | |||
| Z Score | 11.4 | |||
| Net Asset | 41.96 B |
About Kainos Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kainos Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kainos Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kainos Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kainos Medicine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kainos Medicine's short interest history, or implied volatility extrapolated from Kainos Medicine options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Kainos Medicine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Kainos Medicine information on this page should be used as a complementary analysis to other Kainos Medicine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Kainos Stock analysis
When running Kainos Medicine's price analysis, check to measure Kainos Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kainos Medicine is operating at the current time. Most of Kainos Medicine's value examination focuses on studying past and present price action to predict the probability of Kainos Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kainos Medicine's price. Additionally, you may evaluate how the addition of Kainos Medicine to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |